Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Development and validation of quick Acute Kidney Injury-score (q-AKI) to predict acute kidney injury at admission to a multidisciplinary intensive care unit.

Ferrari F, Puci MV, Ferraro OE, Romero-González G, Husain-Syed F, Rizo-Topete L, Senzolo M, Lorenzin A, Muraro E, Baracca A, Serrano-Soto M, Molano Triviño A, Coutinho Castro A, De Cal M, Corradi V, Brendolan A, Scarpa M, Carta MR, Giavarina D, Bonato R, Iotti GA, Ronco C.

PLoS One. 2019 Jun 20;14(6):e0217424. doi: 10.1371/journal.pone.0217424. eCollection 2019.

2.

Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.

Cox MC, Castiello L, Mattei M, Santodonato L, D'Agostino G, Muraro E, Martorelli D, Lapenta C, Di Napoli A, Di Landro F, Cangemi M, Pavan A, Castaldo P, Hohaus S, Donati S, Montefiore E, Berdini C, Carlei D, Monque DM, Ruco L, Prosperi D, Tafuri A, Spadaro F, Sestili P, Spada M, Dolcetti R, Santini SM, Rozera C, Aricò E, Capone I, Belardelli F.

Clin Cancer Res. 2019 Sep 1;25(17):5231-5241. doi: 10.1158/1078-0432.CCR-19-0709. Epub 2019 Jun 6.

PMID:
31171545
3.

Epidemiologic, Imaging, Audiologic, Clinical, Surgical, and Prognostic Issues in Common Cavity Deformity: A Narrative Review.

Brotto D, Avato I, Lovo E, Muraro E, Bovo R, Trevisi P, Martini A, Manara R.

JAMA Otolaryngol Head Neck Surg. 2019 Jan 1;145(1):72-78. doi: 10.1001/jamaoto.2018.2839.

PMID:
30419122
4.

Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient.

Caccuri F, Muraro E, Gloghini A, Turriziani O, Riminucci M, Giagulli C, Mastorci K, Fae' DA, Fiorentini S, Caruso A, Carbone A, Dolcetti R.

Hematol Oncol. 2019 Apr;37(2):176-184. doi: 10.1002/hon.2562. Epub 2018 Nov 6.

PMID:
30261551
5.

Fistula Cannulation with a Novel Fistula Cannula: A Review of Cannulation Devices and Procedures.

Nalesso F, Garzotto F, Muraro E, Brendolan A, Ronco C.

Blood Purif. 2018;45(1-3):278-283. doi: 10.1159/000485594. Epub 2018 Jan 26. Review.

6.

Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer.

Muraro E, Furlan C, Avanzo M, Martorelli D, Comaro E, Rizzo A, Fae' DA, Berretta M, Militello L, Del Conte A, Spazzapan S, Dolcetti R, Trovo' M.

Front Immunol. 2017 Nov 6;8:1476. doi: 10.3389/fimmu.2017.01476. eCollection 2017.

7.

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy.

Montico B, Lapenta C, Ravo M, Martorelli D, Muraro E, Zeng B, Comaro E, Spada M, Donati S, Santini SM, Tarallo R, Giurato G, Rizzo F, Weisz A, Belardelli F, Dolcetti R, Dal Col J.

Oncoimmunology. 2017 Jul 31;6(11):e1356964. doi: 10.1080/2162402X.2017.1356964. eCollection 2017.

8.

Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.

Trovo M, Furlan C, Polesel J, Fiorica F, Arcangeli S, Giaj-Levra N, Alongi F, Del Conte A, Militello L, Muraro E, Martorelli D, Spazzapan S, Berretta M.

Radiother Oncol. 2018 Jan;126(1):177-180. doi: 10.1016/j.radonc.2017.08.032. Epub 2017 Sep 21.

PMID:
28943046
9.

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.

Muraro E, Merlo A, Martorelli D, Cangemi M, Dalla Santa S, Dolcetti R, Rosato A.

Front Immunol. 2017 Feb 27;8:197. doi: 10.3389/fimmu.2017.00197. eCollection 2017. Review.

10.

Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer.

Miolo G, Muraro E, Caruso D, Crivellari D, Ash A, Scalone S, Lombardi D, Rizzolio F, Giordano A, Corona G.

Oncotarget. 2016 Jun 28;7(26):39809-39822. doi: 10.18632/oncotarget.9489.

11.

Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.

Mastorci K, Muraro E, Pasini E, Furlan C, Sigalotti L, Cinco M, Dolcetti R, Fratta E.

PLoS One. 2016 Apr 28;11(4):e0153823. doi: 10.1371/journal.pone.0153823. eCollection 2016.

12.

Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy.

Faè DA, Martorelli D, Mastorci K, Muraro E, Dal Col J, Franchin G, Barzan L, Comaro E, Vaccher E, Rosato A, Dolcetti R.

Cancer Immunol Res. 2016 May;4(5):431-40. doi: 10.1158/2326-6066.CIR-15-0108. Epub 2016 Mar 23.

13.

Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study.

Trovo M, Giaj-Levra N, Furlan C, Bortolin MT, Muraro E, Polesel J, Minatel E, Tedeschi R, Filippi AR, Alongi F, Ricardi U.

Clin Transl Oncol. 2016 Oct;18(10):1003-10. doi: 10.1007/s12094-015-1473-x. Epub 2015 Dec 21.

PMID:
26687367
14.

Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.

Dolcetti R, Giagulli C, He W, Selleri M, Caccuri F, Eyzaguirre LM, Mazzuca P, Corbellini S, Campilongo F, Marsico S, Giombini E, Muraro E, Rozera G, De Paoli P, Carbone A, Capobianchi MR, Ippolito G, Fiorentini S, Blattner WA, Lu W, Gallo RC, Caruso A.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14331-6. doi: 10.1073/pnas.1514748112. Epub 2015 Nov 2. Erratum in: Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):E7033.

15.

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.

Muraro E, Comaro E, Talamini R, Turchet E, Miolo G, Scalone S, Militello L, Lombardi D, Spazzapan S, Perin T, Massarut S, Crivellari D, Dolcetti R, Martorelli D.

J Transl Med. 2015 Jun 27;13:204. doi: 10.1186/s12967-015-0567-0.

16.

A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.

Martorelli D, Muraro E, Mastorci K, Dal Col J, Faè DA, Furlan C, Giagulli C, Caccuri F, Rusnati M, Fiorentini S, Carbone A, Caruso A, Dolcetti R.

Int J Cancer. 2015 Sep 15;137(6):1374-85. doi: 10.1002/ijc.29494. Epub 2015 Mar 9.

17.

Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.

Miolo G, Muraro E, Martorelli D, Lombardi D, Scalone S, Spazzapan S, Massarut S, Perin T, Viel E, Comaro E, Talamini R, Bidoli E, Turchet E, Crivellari D, Dolcetti R.

BMC Cancer. 2014 Dec 15;14:954. doi: 10.1186/1471-2407-14-954.

18.

Pregnancy in Alport syndrome: a report of two differently-evolving cases.

Alessi M, Fabris A, Zambon A, Cremasco D, Muraro E, Dosa L, Anglani F, Del Prete D.

J Obstet Gynaecol. 2014 Jan;34(1):98-100. doi: 10.3109/01443615.2013.834299. No abstract available.

PMID:
24359068
19.

Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas.

Muraro E, Martorelli D, Dolcetti R.

Hum Vaccin Immunother. 2013 May;9(5):1078-83. doi: 10.4161/hv.23970. Epub 2013 Feb 13. Review.

20.

IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas.

Martorelli D, Guidoboni M, De Re V, Muraro E, Turrini R, Merlo A, Pasini E, Caggiari L, Romagnoli L, Spina M, Mortarini R, Gasparotto D, Mazzucato M, Carbone A, Rosato A, Anichini A, Dolcetti R.

Clin Cancer Res. 2012 Aug 1;18(15):4080-91. doi: 10.1158/1078-0432.CCR-12-0763. Epub 2012 Jun 15.

21.

Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.

Martorelli D, Muraro E, Merlo A, Turrini R, Faè DA, Rosato A, Dolcetti R.

Clin Dev Immunol. 2012;2012:931952. doi: 10.1155/2012/931952. Epub 2012 Jan 29. Review.

22.

Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets.

Dal Col J, Mastorci K, Faè DA, Muraro E, Martorelli D, Inghirami G, Dolcetti R.

Cancer Res. 2012 Apr 1;72(7):1825-35. doi: 10.1158/0008-5472.CAN-11-2505. Epub 2012 Feb 6.

23.

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.

Muraro E, Martorelli D, Turchet E, Miolo G, Scalone S, Comaro E, Talamini R, Mastorci K, Lombardi D, Perin T, Carbone A, Veronesi A, Crivellari D, Dolcetti R.

Breast Cancer Res. 2011;13(6):R117. doi: 10.1186/bcr3060.

24.

Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells.

Martorelli D, Coppotelli G, Muraro E, Dolcetti R, Masucci MG.

Cancer Immunol Immunother. 2012 Jun;61(6):881-92. doi: 10.1007/s00262-011-1157-5. Epub 2011 Nov 17.

PMID:
22089857
25.

Cancer vaccines in phase II/III clinical trials: state of the art and future perspectives.

Cecco S, Muraro E, Giacomin E, Martorelli D, Lazzarini R, Baldo P, Dolcetti R.

Curr Cancer Drug Targets. 2011 Jan;11(1):85-102. Review.

PMID:
21062241
26.

Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.

Martorelli D, Muraro E, Merlo A, Turrini R, Rosato A, Dolcetti R.

Int Rev Immunol. 2010 Aug;29(4):371-402. doi: 10.3109/08830185.2010.489658. Review.

PMID:
20635880
27.

The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders.

Merlo A, Turrini R, Dolcetti R, Martorelli D, Muraro E, Comoli P, Rosato A.

Haematologica. 2010 Oct;95(10):1769-77. doi: 10.3324/haematol.2010.023689. Epub 2010 Apr 26. Review.

28.

Role of interventional radiology in the treatment of biliary strictures following orthotopic liver transplantation.

Righi D, Cesarani F, Muraro E, Gazzera C, Salizzoni M, Gandini G.

Cardiovasc Intervent Radiol. 2002 Jan-Feb;25(1):30-5. Epub 2002 Jan 17.

PMID:
11907771

Supplemental Content

Loading ...
Support Center